Deccan Health Care Ltd vs Global Longlife Hospital And Research Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Nov 01, 2026

Key Highlights

The Latest Trading Price of Deccan Health Care Ltd is ₹ 12.02 as of 30 Oct 15:30 . The P/E Ratio of Deccan Health Care Ltd changed from 117.6 on March 2021 to 6.8 on March 2026 . This represents a CAGR of -37.82% over 6 yearsThe P/E Ratio of Global Longlife Hospital and Research Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Deccan Health Care Ltd changed from ₹ 46.2 crore on March 2021 to ₹ 16.95 crore on March 2026 . This represents a CAGR of -15.39% over 6 yearsThe Market Cap of Global Longlife Hospital and Research Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 years The revenue of Deccan Health Care Ltd for the Jun '26 is ₹ 22.09 crore as compare to the Mar '26 revenue of ₹ 20.98 crore. This represent the growth of 5.29% The revenue of Global Longlife Hospital and Research Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Deccan Health Care Ltd for the Jun '26 is ₹ 0.93 crore as compare to the Mar '26 ebitda of ₹ 0.89 crore. This represent the growth of 4.49% The ebitda of Global Longlife Hospital and Research Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Deccan Health Care Ltd changed from ₹ 0.36 crore to ₹ 0.29 crore over 9 quarters. This represents a CAGR of -9.16% The net profit of Global Longlife Hospital and Research Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The Dividend Payout of Deccan Health Care Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Global Longlife Hospital and Research Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Deccan Health Care Ltd

Incorporated on August 31, 2017, Deccan Health Care Limited is developing, manufacturing and marketing a broad range of healthcare products including nutraceutical, cosmeceutical and ayurveda products.
With an operating history of more than two decades, the company is primarily known for premium range of nutraceutical, ayurveda and cosmeceutical products.
The Company has identified over 80 consumer wellness goals and over 250 diseases, disorders, disabilities which can be prevented by meeting RDA of micronutrients and it has innovated and developed cost effective products that are unique and differentiated to combat such diseases. The Company was initially engaged in trading of Pharmaceuticals till 2005.
From 2005 till 2010 the company was engaged in third party manufacturing.
From 2010 onwards, the Company set up its own Manufacturing Facility at Rudrapur, Uttarakhand.

About Global Longlife Hospital and Research Ltd

Global Longlife Hospital and Research Limited was originally incorporated as 'Global Longlife Hospital and Research Private Limited' on January 20, 2012 with Registrar of Companies, Gujarat.
Subsequently, Company was converted into a Public Limited Company and , name of the Company was changed to 'Global Longlife Hospital and Research Limited' vide fresh Certificate of Incorporation dated August 31, 2021. The Company had acquired 1339 sq.mt. area land in the prime locality of Ahmedabad for starting hospital in March 2012.
The Hospital started journey in 2015 & determined to build an institution in Ahmedabad.
Mr. Dhruv Jani had also joined the hospital business with his father in July 2015.
The majority Equity shares of the Company were taken over by the present Promoters by acquiring the Equity shares from the Doctors and investors in the year 2017.

FAQs for the comparison of Deccan Health Care Ltd and Global Longlife Hospital and Research Ltd

Which company has a larger market capitalization, Deccan Health Care Ltd or Global Longlife Hospital and Research Ltd?

Market cap of Deccan Health Care Ltd is 29 Cr while Market cap of Global Longlife Hospital and Research Ltd is 13 Cr

What are the key factors driving the stock performance of Deccan Health Care Ltd and Global Longlife Hospital and Research Ltd?

The stock performance of Deccan Health Care Ltd and Global Longlife Hospital and Research Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Deccan Health Care Ltd and Global Longlife Hospital and Research Ltd?

As of November 1, 2026, the Deccan Health Care Ltd stock price is INR ₹12.02. On the other hand, Global Longlife Hospital and Research Ltd stock price is INR ₹12.82.

How do dividend payouts of Deccan Health Care Ltd and Global Longlife Hospital and Research Ltd compare?

To compare the dividend payouts of Deccan Health Care Ltd and Global Longlife Hospital and Research Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.